CDE Catalog

View and download available CureSCi CDEs using filters below. For best results, clear form between searches.

Displaying 5151 - 5175 of 5231
Operations
Selected 25 rows in this page.  
The search results below can be downloaded by clicking the checkboxes on the far right side of the table. Select the header checkbox to select all CDEs listed on the first page. Then choose CDE Detailed Report from the Choose an operation dropdown menu.
CDE ID CDE Name Definition Classification Version Number Version Date CRF Name ©, ® or TM Disease Name Sub Disease Name
C60632 Complete blood count current text

Text field for specifying the current complete blood count (CBC)

Core 1.00 2021-04-29 16:19:24.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60633 Hemoglobin analysis current text

Text field for specifying the current hemoglobin analysis.

Core 1.00 2021-04-29 16:19:24.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60634 Tissue monitoring anatomic site

Anatomic site from which tissue for monitoring was sampled.

Core 1.00 2021-04-29 16:23:35.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60635 Tissue monitoring type

Type of tissue sampled for monitoring

Core 1.00 2021-04-29 16:24:47.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60636 Bone marrow cell sort indicator

Indicator of whether bone marrow cells were sorted.

Core 1.00 2021-04-29 16:26:43.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60637 Bone marrow cell sort immunophenotype indicator

Indicator of whether bone marrow cells were sorted by immunophenotype.

Core 1.00 2021-04-29 16:28:12.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60638 Blood CD3 deplete indicator

Indicator of whether blood is depleted of CD3.

Core 1.00 2021-04-30 11:18:09.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60639 Blood CD3 depleted conversion percent value

Value of the percentage of conversions related to CD3 depletion in blood.

Core 1.00 2021-04-30 11:22:27.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60640 Gene editing site specific nuclease indel on target percent value

Value of the percentage of on-target indels in blood for site-specific nuclease gene editing.

Core 1.00 2021-04-30 11:24:37.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60641 Gene editing site specific nuclease indel off target percent value

Value of the percentage of off-target indels in blood for site-specific nuclease gene editing.

Core 1.00 2021-04-30 11:24:37.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60650 Site specific nuclease gene edit on target frequency method type

Type of method used for determining on-target frequency of gene editing for site-specific nucleases.

Core 1.00 2021-04-30 11:52:35.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60651 Reporter gene assay method specify text

Text specifying the type of reporter gene assay used.

Core 1.00 2021-04-30 11:58:46.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60652 On target indel frequency associate adverse outcome indicator

Indicator of whether the on-target indel frequency is associated with an adverse outcome.

Core 1.00 2021-04-30 12:02:06.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60653 On target indel frequency associate adverse outcome describe text

Text field for describing the adverse outcome (if any) associated with on-target indel frequency.

Core 1.00 2021-04-30 12:03:35.0 Gene Product Follow-Up Sickle Cell Disease Sickle Cell Disease
C60655 PROMIS Pediatric Global Health 7 plus 2 - very sad feel frequency scale

Scale for the frequency with which the subject/participant feels very sad, as part of the PROMIS Pediatric Global Health 7+2 questionnaire.

Core 1.00 2021-04-30 12:55:04.0 PROMIS Pediatric Global Health 7+2 Sickle Cell Disease Sickle Cell Disease
C60656 PROMIS Pediatric Global Health 7plus 2 - fun with friend frequency scale

Scale of the frequency with which the subject/participant has fun with friends, as part of the PROMIS Pediatric Global Health 7+2 questionnaire.

Core 1.00 2021-04-30 13:00:50.0 PROMIS Pediatric Global Health 7+2 Sickle Cell Disease Sickle Cell Disease
C60657 PROMIS Pediatric Global Health 7 plus 2 - parent listen idea frequency scale

Scale of the frequency with which the subject/participant's parents listen to his or her ideas, as part of the PROMIS Pediatric Global Health 7+2 questionnaire.

Core 1.00 2021-04-30 13:03:40.0 PROMIS Pediatric Global Health 7+2 Sickle Cell Disease Sickle Cell Disease
C60658 PROMIS Pediatric Global Health 7 Plus 2 - tire easily past 7 day frequency scale

Scale of the frequency in the past 7 days with which the subject/participant got tired easily, as part of the PROMIS Pediatric Global Health 7+2 questionnaire.

Core 1.00 2021-04-30 13:06:33.0 PROMIS Pediatric Global Health 7+2 Sickle Cell Disease Sickle Cell Disease
C60659 PROMIS Pediatric Global Health 7 Plus 2 - trouble sleep with pain past 7 day frequency scale

Scale of the frequency over the past 7 days with which the subject/participant had trouble sleeping when he or she was experiencing pain, as part of the PROMIS Pediatric Global Health 7+2 questionnaire.

Core 1.00 2021-04-30 13:10:14.0 PROMIS Pediatric Global Health 7+2 Sickle Cell Disease Sickle Cell Disease
C60683 Gene ediing target Indels conversion percentage value

The percentage value related to conversion.

Core 1.00 2021-05-10 12:12:04.0 Drug Product Sickle Cell Disease Sickle Cell Disease
C60691 Apheresis mobilization agent plerixafor prior collection time value

The value related to time prior to collection for administration of plerixafor for mobilization agent in apheresis.

Exploratory 1.00 2021-05-10 12:12:04.0 Apheresis Sickle Cell Disease Sickle Cell Disease
C60675 Vector copy number to cell value

The value related to vector copy number/cells

Core 1.00 2021-05-10 12:12:04.0 Drug Product Sickle Cell Disease Sickle Cell Disease
C60714 Apheresis product hematocrit percentage value

The percentage value of hematocrit in apheresis product

Exploratory 1.00 2021-05-10 12:12:04.0 Apheresis Sickle Cell Disease Sickle Cell Disease
C60661 Genetic therapy product manufacture date

The date related to study treatment manufacture

Supplemental 1.00 2021-05-10 12:12:04.0 Drug Product Sickle Cell Disease Sickle Cell Disease
C60669 Genetic therapy subcategory treatment type

The type of study treatment subcategory.

Supplemental 1.00 2021-05-10 12:12:04.0 Drug Product Sickle Cell Disease Sickle Cell Disease
Displaying 5151 - 5175 of 5231